Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 356

The DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.

Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease

Open access
Mitrofanova, Alla, Merscher, Sandra, Fornoni, Alessia·2023·Nature Reviews Nephrology

Abstract

Chronic kidney disease (CKD) is a global health problem with rising incidence and prevalence. Among several pathogenetic mechanisms responsible for disease progression, lipid accumulation in the kidney parenchyma might drive inflammation and fibrosis, as has been described in fatty liver diseases. Lipids and their metabolites have several important structural and functional roles, as they are constituents of cell and organelle membranes, serve as signalling molecules and are used for energy production. However, although lipids can be stored in lipid droplets to maintain lipid homeostasis, lipid accumulation can become pathogenic. Understanding the mechanisms linking kidney parenchymal lipid accumulation to CKD of metabolic or non-metabolic origin is challenging, owing to the tremendous variety of lipid species and their functional diversity across different parenchymal cells. Nonetheless, multiple research reports have begun to emphasize the effect of dysregulated kidney lipid metabolism in CKD progression. For example, altered cholesterol and fatty acid metabolism contribute to glomerular and tubular cell injury. Newly developed lipid-targeting agents are being tested in clinical trials in CKD, raising expectations for further therapeutic development in this field. Chronic kidney disease is characterized by dyslipidaemia and lipid accumulation in the kidney. In this Review, the authors examine the evidence that links alterations in lipid metabolism to kidney injury and progression of kidney disease, and explore potential lipid-targeted therapeutic approaches. Lipids and lipid-related enzymes have a major role in modulating the function of glomerular and tubular cells, and can drive chronic kidney disease (CKD) irrespective of circulating lipid levels. The mechanisms that initiate the accumulation of kidney lipids might differ between CKD of different aetiologies. Thus, the accumulation of kidney lipids in diabetic kidney disease is driven by increased glucose and fatty acids levels owing to insulin resistance, whereas in glomerulonephritis, inflammation can disrupt normal kidney lipid metabolism. Several lipid species, such as cholesterol, triglycerides, fatty acids and phospholipids, are dysregulated in podocytes, endothelial and tubular cells, and contribute to CKD progression. Accumulation of kidney parenchymal cholesterol occurs in association with impaired reverse cholesterol transport in diseases of both metabolic and non-metabolic origin, and contributes to CKD progression. Accumulation of fatty acids triggers mitochondrial and kidney cell damage by promoting inflammation, including cellular sterile inflammation, via innate immune system activation and fibrosis; lipophagy has a protective effect. Lipids and lipid-related enzymes have a major role in modulating the function of glomerular and tubular cells, and can drive chronic kidney disease (CKD) irrespective of circulating lipid levels. The mechanisms that initiate the accumulation of kidney lipids might differ between CKD of different aetiologies. Thus, the accumulation of kidney lipids in diabetic kidney disease is driven by increased glucose and fatty acids levels owing to insulin resistance, whereas in glomerulonephritis, inflammation can disrupt normal kidney lipid metabolism. Several lipid species, such as cholesterol, triglycerides, fatty acids and phospholipids, are dysregulated in podocytes, endothelial and tubular cells, and contribute to CKD progression. Accumulation of kidney parenchymal cholesterol occurs in association with impaired reverse cholesterol transport in diseases of both metabolic and non-metabolic origin, and contributes to CKD progression. Accumulation of fatty acids triggers mitochondrial and kidney cell damage by promoting inflammation, including cellular sterile inflammation, via innate immune system activation and fibrosis; lipophagy has a protective effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41581-023-00741-w

Cites

249 of 249 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 249 references

Cited by

See all 356

Metadata

Authors
Mitrofanova, A., Merscher, S., & Fornoni, A.
Venue
Nature Reviews Nephrology
Published
2023-07-27
Volume
19
Issue
10
Pages
629-645
ISSN
  • 1745-8323 (ISSN-L)
  • 1759-5061
  • 1759-507X
OpenAlex
W4385331218
Cited by
356
References
249
FWCI
20.93
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. https://app.cochat.ai/papers/10.1038/s41581-023-00741-w
The paper
Mitrofanova, A., Merscher, S., & Fornoni, A. (2023). Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nature Reviews Nephrology. https://doi.org/10.1038/s41581-023-00741-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.